{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:02:29Z","timestamp":1785888149071,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.tmrv.2019.12.002","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T20:03:42Z","timestamp":1580155422000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Early Use of Fibrinogen Replacement Therapy in Postpartum Hemorrhage\u2014A Systematic Review"],"prefix":"10.1016","volume":"34","author":[{"given":"Abbas","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Daru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2019.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0010","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0015","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/1471-0528.13831","article-title":"The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study","volume":"123","author":"Green","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-011-2315-0","article-title":"Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study","volume":"37","author":"Gayat","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"P.D. de. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/bja\/aes096","article-title":"Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial","volume":"108","author":"Cortet","year":"2012","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0035","article-title":"o.b.t.R.C.o.O.a.a. Gynaecologists. Prevention and management of postpartum haemorrhage","author":"Mavrides","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0040","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/17474086.2016.1245135","article-title":"Postpartum haemorrhage: prevention and treatment","volume":"9","author":"Sentilhes","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.15167","article-title":"British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding","volume":"181","author":"Green","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-018-2086-x","article-title":"Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial","volume":"22","author":"Curry","year":"2018","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.tmrv.2019.12.002_bb0055","article-title":"Fibrinogen concentrate in bleeding patients","author":"Wikkelso","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1399-6576.2011.02586.x","article-title":"Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults","volume":"56","author":"Warmuth","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/aas.12370","article-title":"Fibrinogen concentrate for bleeding\u2014a systematic review","volume":"58","author":"Lunde","year":"2014","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0070","article-title":"Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia","volume":"12","author":"Fabes","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.02.023","article-title":"Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines","volume":"213","author":"Dahlke","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0085","series-title":"Australian New Zealand Clinical Trials Registry","article-title":"The effect of Upfront Administration of Fibrinogen concentrate on total blood volume loss in Obstetric Haemorrhage \u2013 A Pilot study","author":"J.v.d. Westhuizen","year":"2014"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-3148.2012.01178.x","article-title":"O.R. J.M, B.M. Byrne. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage\u2014an observational study","volume":"22","author":"Ahmed","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijoa.2009.08.004","article-title":"The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage","volume":"19","author":"Bell","year":"2010","journal-title":"Int J Obstet Anesth"},{"issue":"Supplement 1","key":"10.1016\/j.tmrv.2019.12.002_bb0100","first-page":"S51","article-title":"Effect of fibrinogen concentrate administration on maternal morbidity in the treatment of severe postpartum haemorrhage","volume":"31","author":"Deleu","year":"2017","journal-title":"Int J Obstet Anesth."},{"key":"10.1016\/j.tmrv.2019.12.002_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/bjh.14804","article-title":"Fibrinogen concentration and use of fibrinogen supplementation with cryoprecipitate in patients with critical bleeding receiving massive transfusion: a bi-national cohort study","volume":"179","author":"McQuilten","year":"2017","journal-title":"Br J Haematol"},{"issue":"Supplement 2","key":"10.1016\/j.tmrv.2019.12.002_bb0110","first-page":"166","article-title":"Analysis of influence of clinical outcomes of cryoprecipitate infusion in patients with early postpartum hemorrhagic shock","volume":"112","author":"Wen","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0115","unstructured":"I. Akira. Invasive intervention study of the safety of fibrinogen concentrate used in obstetric hemorrhage (SFOH study). 2019. https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000025568"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0120","series-title":"Use of Prothrombin Complex Concentrate and Fibrinogen Compared With Fresh Frozen Plasma (and Fibrinogen if Needed) in the Treatment of Postpartum Haemorrhage","author":"Ahonen","year":"2013"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/bja\/aex181","article-title":"Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial","volume":"119","author":"Collins","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bja\/aeu444","article-title":"F.-P.t. group. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial","volume":"114","author":"Wikkelso","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0135","series-title":"Administering cryoprecipitate in obstetric bleeding at an earlier time (ACROBAT)","author":"Green","year":"2019"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0140","series-title":"A Program to Evaluate Riastap\u00ae and FIBTEM\u00ae for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)","author":"Paidas","year":"2015"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0145","first-page":"293","article-title":"Fibrinogen concentrate as a treatment for postpartum haemorrhage-induced coagulopathy: A study protocol for a randomised multicentre controlled trial. The fibrinogen in haemorrhage of DELivery (FIDEL) trial","volume":"35","author":"Ducloy-Bouthors","year":"2016","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0150","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2019.12.002_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/1471-0528.15335","article-title":"Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study","volume":"126","author":"Meher","year":"2019","journal-title":"BJOG"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796320300092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796320300092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:29Z","timestamp":1760138309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796320300092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0887796320300092"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.12.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Use of Fibrinogen Replacement Therapy in Postpartum Hemorrhage\u2014A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}